Is this your podcast?
Sign up
to track ranks and reviews from Spotify, Apple Podcasts and more
Riding Unicorns
Riding Unicorns is the podcast about venture capital and growth startups. The show is co-hosted by two Venture Capitalists, James Pringle at Mercuri, and Hector Mason at Episode 1 Ventures. The show delves into the operational aspects of building successful tech unicorns, featuring interviews with top-notch founders and investors in the venture space. Whether you are a founder, VC, angel investor or just curious about the space, each episode is unique and goes into different topics related to tech and venture so we hope you enjoy it and take away something useful.
Listen now
Ratings & Reviews
☆
☆
☆
☆
☆
4.9 stars from 14 ratings
Great entrepreneurial guests
☆
☆
☆
☆
☆
“I love listening to the founder stories. It's so interesting to hear how they started and grew their businesses.”Read full review »
Alfalfabuig via Apple Podcasts ·
Great Britain ·
01/13/21
“Have thoroughly enjoyed listening to Riding Unicorns. As an entrepreneur myself it’s been fascinating hearing about how some of the most successful people in business have done it. Looking forward to future episodes.”
Hee234 via Apple Podcasts ·
Great Britain ·
11/25/20
“It may just be a personal thing but I get distracted with very obvious editing in podcasts. It disrupts the flow and natural element of a conversation and becomes very cold and robotic. Unfortunately that’s very evident in this series. Aside from this annoyance, really insightful content.”
Joey Robbo via Apple Podcasts ·
Great Britain ·
10/27/20
Recent Episodes
Johannes Weber is the Founding Partner at Ananda Impact Ventures, the leading impact venture capital fund with a pan-European investment remit, managing ca. €200 million in four Core Impact Funds, with backing from notable institutional and private investors. They back technology businesses...
Published 04/10/24
Published 04/10/24
Meri Beckwith is a Co-Founder at Lindus Health. Their mission is to accelerate clinical trials, so patients can benefit from new treatments sooner. They are an anti-CRO running radically faster, more reliable clinical trials for life science pioneers. They do this thanks to a commercial model...
Published 04/03/24
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
